Human embryonic stem cell therapy for aplastic anemia

Human embryonic stem cell (hESC) therapy is the potential therapeutic option for the treatment of patients with aplastic anemia (AA). The study showed a remarkable improvement in the AA patient subsequent to hESC administration. No adverse events occurred in the patient. hESC therapy is safe and eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Shroff, Geeta, Gupta, Rakesh, Zadeng, Lalduhawmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458044/
https://www.ncbi.nlm.nih.gov/pubmed/28588839
http://dx.doi.org/10.1002/ccr3.950
_version_ 1783241671158267904
author Shroff, Geeta
Gupta, Rakesh
Zadeng, Lalduhawmi
author_facet Shroff, Geeta
Gupta, Rakesh
Zadeng, Lalduhawmi
author_sort Shroff, Geeta
collection PubMed
description Human embryonic stem cell (hESC) therapy is the potential therapeutic option for the treatment of patients with aplastic anemia (AA). The study showed a remarkable improvement in the AA patient subsequent to hESC administration. No adverse events occurred in the patient. hESC therapy is safe and effective for AA patients.
format Online
Article
Text
id pubmed-5458044
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-54580442017-06-06 Human embryonic stem cell therapy for aplastic anemia Shroff, Geeta Gupta, Rakesh Zadeng, Lalduhawmi Clin Case Rep Case Reports Human embryonic stem cell (hESC) therapy is the potential therapeutic option for the treatment of patients with aplastic anemia (AA). The study showed a remarkable improvement in the AA patient subsequent to hESC administration. No adverse events occurred in the patient. hESC therapy is safe and effective for AA patients. John Wiley and Sons Inc. 2017-04-26 /pmc/articles/PMC5458044/ /pubmed/28588839 http://dx.doi.org/10.1002/ccr3.950 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Shroff, Geeta
Gupta, Rakesh
Zadeng, Lalduhawmi
Human embryonic stem cell therapy for aplastic anemia
title Human embryonic stem cell therapy for aplastic anemia
title_full Human embryonic stem cell therapy for aplastic anemia
title_fullStr Human embryonic stem cell therapy for aplastic anemia
title_full_unstemmed Human embryonic stem cell therapy for aplastic anemia
title_short Human embryonic stem cell therapy for aplastic anemia
title_sort human embryonic stem cell therapy for aplastic anemia
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458044/
https://www.ncbi.nlm.nih.gov/pubmed/28588839
http://dx.doi.org/10.1002/ccr3.950
work_keys_str_mv AT shroffgeeta humanembryonicstemcelltherapyforaplasticanemia
AT guptarakesh humanembryonicstemcelltherapyforaplasticanemia
AT zadenglalduhawmi humanembryonicstemcelltherapyforaplasticanemia

Ejemplares similares